Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech company developing innovative treatments for diseases with high unmet medical needs, today announced that the Company has entered into a financing agreement (the “Financing Agreement”) securing loan financing of at least 250 MSEK. The Financing Agreement includes a cash loan in …
